Seguir
Ie-Ming Shih
Ie-Ming Shih
Johns Hopkins University Department of Gynecology and Obstetrics
Dirección de correo verificada de jhmi.edu - Página principal
Título
Citado por
Citado por
Año
The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory
RJ Kurman, IM Shih
The American journal of surgical pathology 34 (3), 433-443, 2010
24032010
ARID1A mutations in endometriosis-associated ovarian carcinomas
KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ...
New England Journal of Medicine 363 (16), 1532-1543, 2010
19692010
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
PJ Killela, ZJ Reitman, Y Jiao, C Bettegowda, N Agrawal, LA Diaz Jr, ...
Proceedings of the National Academy of Sciences 110 (15), 6021-6026, 2013
15972013
Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis
IM Shih, RJ Kurman
The American journal of pathology 164 (5), 1511-1518, 2004
15742004
Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma
S Jones, TL Wang, IM Shih, TL Mao, K Nakayama, R Roden, R Glas, ...
Science 330 (6001), 228-231, 2010
14622010
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—shifting the paradigm
RJ Kurman, IM Shih
Human pathology 42 (7), 918-931, 2011
14612011
The dualistic model of ovarian carcinogenesis: revisited, revised, and expanded
RJ Kurman, IM Shih
The American journal of pathology 186 (4), 733-747, 2016
11712016
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer, R Oldt III, Y Cohen, BG Wang, D Sidransky, RJ Kurman, IM Shih
Journal of the National Cancer Institute 95 (6), 484-486, 2003
11172003
Ovarian cancer
KR Cho, IM Shih
Annual review of pathology: mechanisms of disease 4 (1), 287-313, 2009
10142009
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
9692016
Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems
R Vang, IM Shih, RJ Kurman
Advances in anatomic pathology 16 (5), 267-282, 2009
8032009
Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications
RJ Kurman, IM Shih
International Journal of Gynecological Pathology 27 (2), 151-160, 2008
7532008
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers
CM Sturgeon, MJ Duffy, UH Stenman, H Lilja, N Brunner, DW Chan, ...
Clinical chemistry 54 (12), e11-e79, 2008
7512008
High grade serous ovarian carcinomas originate in the fallopian tube
SI Labidi-Galy, E Papp, D Hallberg, N Niknafs, V Adleff, M Noe, ...
Nature communications 8 (1), 1093, 2017
7402017
Synthetic lethality by targeting EZH2 methyltransferase activity in ARID1A-mutated cancers
BG Bitler, KM Aird, A Garipov, H Li, M Amatangelo, AV Kossenkov, ...
Nature medicine 21 (3), 231-238, 2015
6582015
The role of chromosomal instability in tumor initiation
MA Nowak, NL Komarova, A Sengupta, PV Jallepalli, IM Shih, ...
Proceedings of the National Academy of Sciences 99 (25), 16226-16231, 2002
6432002
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
6352019
Cancer-associated mutations in endometriosis without cancer
MS Anglesio, N Papadopoulos, A Ayhan, TM Nazeran, M Noë, ...
New England Journal of Medicine 376 (19), 1835-1848, 2017
6212017
Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
A Yemelyanova, R Vang, M Kshirsagar, D Lu, MA Marks, IM Shih, ...
Modern pathology 24 (9), 1248-1253, 2011
5922011
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
5862011
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20